摘要

Eight different batches of intravenous immunoglobulin from 3 different manufacturers were tested for neutralizing activities against all currently known streptococcal super-antigens. Statistically significant variation among different intravenous immunoglobulin preparations (P < .001) and P between individual streptococcal superantigens (P < .0001) was observed. These results might be helpful for optimizing the type and dose of intravenous immunoglobulin used in adjunctive therapy for severe invasive streptococcal disease.

  • 出版日期2006-9-15